Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab

Given the increasing use of combination therapy with multiple monoclonal antibodies (mAbs), there is a clinical need for multiplexing assays. For the frequently co-administered anti-human epidermal growth factor receptor 2 (HER2) mAbs trastuzumab and pertuzumab, we developed a high-throughput and ro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Schokker, Sandor, Fusetti, Fabrizia, Bonardi, Francesco, Molenaar, Remco J., Mathôt, Ron A.A., van Laarhoven, Hanneke W.M.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531571/
https://ncbi.nlm.nih.gov/pubmed/32744170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2020.1795492
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados